Evaluation of Efficacy and Safety of Latanoprost/Timolol versus Travoprost/Timolol Fixed Combinations for Ocular Hypertension Associated with Uveitis.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Works matching DE "TRAVOPROST"
Results: 64
1
2
Latanoprost Tedavisine Dirençli Primer Açık Açılı Glokom Olgularında Bimatoprost veya Travoprost Monoterapisine Geçişlerde Oluşan Etkinliklerin Değerlendirilmesi.
- Published in:
- Turkish Journal of Ophthalmology / Turk Oftalmoloji Dergisi, 2011, v. 41, n. 5, p. 295, doi. 10.4274/tjo.41.36844
- By:
- Publication type:
- Article
3
Analysis of the Responsiveness of Latanoprost, Travoprost, Bimatoprost, and Tafluprost in the Treatment of OAG/OHT Patients.
- Published in:
- Journal of Ophthalmology, 2021, p. 1, doi. 10.1155/2021/5586719
- By:
- Publication type:
- Article
4
Adherence may increase with generics.
- Published in:
- Optometry Times, 2015, v. 7, n. 4, p. 1
- By:
- Publication type:
- Article
5
Effects of corneal thickness on the intraocular penetration of travoprost 0.004%.
- Published in:
- Eye (0950-222X), 2012, v. 26, n. 7, p. 972, doi. 10.1038/eye.2012.74
- By:
- Publication type:
- Article
6
Efficacy of two trabecular micro-bypass stents combined with topical travoprost in open-angle glaucoma not controlled on two preoperative medications: 3-year follow-up.
- Published in:
- Clinical Ophthalmology, 2017, v. 11, p. 523, doi. 10.2147/OPTH.S121041
- By:
- Publication type:
- Article
7
Efficacy and tolerability of benzalkonium chloride-free travoprost in glaucoma patients switched from benzalkonium chloride-preserved latanoprost or bimatoprost.
- Published in:
- Clinical Ophthalmology, 2016, v. 10, p. 2085, doi. 10.2147/OPTH.S112711
- By:
- Publication type:
- Article
8
Feasibility study of sustained-release travoprost punctum plug for intraocular pressure reduction in an Asian population.
- Published in:
- Clinical Ophthalmology, 2016, v. 10, p. 757, doi. 10.2147/OPTH.S102181
- By:
- Publication type:
- Article
9
Efficacy and safety of fixed-combination travoprost 0.004%/timolol 0.5% in patients transitioning from bimatoprost 0.03%/timolol 0.5% combination therapy.
- Published in:
- Clinical Ophthalmology, 2015, v. 9, p. 825, doi. 10.2147/OPTH.S80880
- By:
- Publication type:
- Article
10
Safety and efficacy of travoprost solution for the treatment of elevated intraocular pressure.
- Published in:
- Clinical Ophthalmology, 2015, v. 9, p. 633, doi. 10.2147/OPTH.S61444
- By:
- Publication type:
- Article
11
The diurnal and nocturnal effects of travoprost in normal-tension glaucoma.
- Published in:
- Clinical Ophthalmology, 2014, v. 8, p. 2189, doi. 10.2147/OPTH.S73125
- By:
- Publication type:
- Article
12
Two-year results of microcatheter-assisted trabeculotomy in paediatric glaucoma: a randomized controlled study.
- Published in:
- Acta Ophthalmologica (1755375X), 2017, v. 95, n. 8, p. e713, doi. 10.1111/aos.13414
- By:
- Publication type:
- Article
13
Effects of SofZia-preserved travoprost and benzalkonium chloride-preserved latanoprost on the ocular surface - a multicentre randomized single-masked study.
- Published in:
- Acta Ophthalmologica (1755375X), 2013, v. 91, n. 1, p. e7, doi. 10.1111/j.1755-3768.2012.02565.x
- By:
- Publication type:
- Article
14
Influence of local application of glaucoma medications-travoprost eye drops on patients' tear film function.
- Published in:
- Pakistan Journal of Pharmaceutical Sciences, 2015, v. 28, p. 781
- By:
- Publication type:
- Article
15
Fixed combination therapy in glaucoma patients.
- Published in:
- Ophthalmology Times Europe, 2015, v. 11, n. 5, p. 30
- By:
- Publication type:
- Article
16
Consistent IOP control in POAG patients.
- Published in:
- Ophthalmology Times Europe, 2015, v. 11, n. 1, p. 10
- By:
- Publication type:
- Article
17
Late-day IOP lowering of BAK-free solution as good as preserved option.
- Published in:
- Ophthalmology Times Europe, 2014, v. 10, n. 10, p. 5
- Publication type:
- Article
18
Patients Achieve Greater 24-Hour IOP Control With DuoTrav® Compared With Latanoprost/ Timolol Fixed Combination.
- Published in:
- Ophthalmology Times Europe, 2015, v. 11, n. 1, p. 7
- Publication type:
- Article
19
The 24-hour effects of travoprost in NTG.
- Published in:
- Ophthalmology Times Europe, 2015, v. 11, n. 1, p. 6
- By:
- Publication type:
- Article
20
Periorbital changes associated with prostaglandin analogs in Korean patients.
- Published in:
- 2017
- By:
- Publication type:
- journal article
21
Effect of benzalkonium chloride-free travoprost on intraocular pressure and ocular surface symptoms in patients with glaucoma previously on latanoprost: an open-label study.
- Published in:
- 2015
- By:
- Publication type:
- journal article
22
Safety and efficacy of travoprost intracameral implant administered in combination with cataract surgery.
- Published in:
- Therapeutic Advances in Ophthalmology, 2025, p. 1, doi. 10.1177/25158414241310275
- By:
- Publication type:
- Article
23
A comparative study on efficacy of fixed combination timolol/brinzolamide versus travoprost monotherapy in drug-naïve open-angle glaucoma patients.
- Published in:
- Therapeutic Advances in Ophthalmology, 2020, v. 12, p. 1, doi. 10.1177/2515841420909666
- By:
- Publication type:
- Article
24
A comparative study on efficacy of fixed combination timolol/brinzolamide versus travoprost monotherapy in drug-naïve open-angle glaucoma patients.
- Published in:
- Therapeutic Advances in Ophthalmology, 2020, v. 12, p. 1, doi. 10.1177/2515841420909666
- By:
- Publication type:
- Article
25
Comparison of Efficacy and Ocular Surface Disease Index Score between Bimatoprost, Latanoprost, Travoprost, and Tafluprost in Glaucoma Patients.
- Published in:
- Journal of Ophthalmology, 2018, p. 1, doi. 10.1155/2018/1319628
- By:
- Publication type:
- Article
26
Prostaglandin associated periorbitopathy in patients using bimatoprost, latanoprost and travoprost.
- Published in:
- Current Medical Literature: Ophthalmology, 2014, v. 24, n. 3, p. 83
- By:
- Publication type:
- Article
27
A Rare Complication: Hypotony and Cystoid Macular Edema due to Travoprost.
- Published in:
- Journal of Glaucoma-Cataract / Glokom-Katarakt, 2014, v. 9, n. 2, p. 137
- By:
- Publication type:
- Article
28
Experimental Evaluation of Travoprost-Induced Changes in Biomechanical Behavior of Ex-Vivo Rabbit Corneas.
- Published in:
- Current Eye Research, 2019, v. 44, n. 1, p. 19, doi. 10.1080/02713683.2018.1516781
- By:
- Publication type:
- Article
29
Prolonged Ocular Inflammation in Endotoxin-Induced Uveitis in Lysosomal Phospholipase A2-Deficient Mice.
- Published in:
- Current Eye Research, 2017, v. 42, n. 4, p. 611, doi. 10.1080/02713683.2016.1214967
- By:
- Publication type:
- Article
30
Correlation of Ocular Surface Disease and Quality of Life in Indian Glaucoma Patients: BAC-preserved versus BAC-free Travoprost.
- Published in:
- Turkish Journal of Ophthalmology / Turk Oftalmoloji Dergisi, 2020, v. 50, n. 2, p. 75, doi. 10.4274/tjo.galenos.2019.29000
- By:
- Publication type:
- Article
31
DEVELOPMENT AND VALIDATION OF THE GAS CHROMATOGRAPHIC METHODS FOR THE DETERMINATION OF ORGANIC VOLATILE IMPURITIES IN TRAVOPROST AND ITS STARTING MATERIAL.
- Published in:
- Acta Poloniae Pharmaceutica, 2020, v. 77, n. 1, p. 23, doi. 10.32383/appdr/115517
- By:
- Publication type:
- Article
32
iDose TR Sustained-release Travoprost Implant for the Treatment of Glaucoma.
- Published in:
- touchREVIEWS in Ophthalmology, 2023, v. 17, n. 1, p. 4, doi. 10.17925/usor.2023.17.1.4
- By:
- Publication type:
- Article
33
Utility of the ganglion cell complex thickness map in glaucoma: the presence of raphe sign.
- Published in:
- Ophthalmology Journal (2450-7873), 2022, v. 7, p. 35, doi. 10.5603/OJ.2022.0006
- By:
- Publication type:
- Article
34
Daily Costs and Cost Effectiveness of Glaucoma Fixed Combinations in China.
- Published in:
- Journal of Ophthalmology, 2020, p. 1, doi. 10.1155/2020/2406783
- By:
- Publication type:
- Article
35
Washout Duration of Prostaglandin Analogues: A Systematic Review and Meta-analysis.
- Published in:
- Journal of Ophthalmology, 2018, p. 1, doi. 10.1155/2018/3190684
- By:
- Publication type:
- Article
36
Study shows sustained effect, high tolerability of drug-eluting insert for glaucoma.
- Published in:
- Ocular Surgery News, 2020, v. 38, n. 14, p. 14
- By:
- Publication type:
- Article
37
Preliminary data show intracameral implant reduces IOP up to 9 months.
- Published in:
- Ocular Surgery News, 2020, v. 38, n. 5, p. 14
- By:
- Publication type:
- Article
38
iDose lowers IOP, shows no significant adverse events in phase 2 trial.
- Published in:
- Ocular Surgery News, 2020, v. 38, n. 5, p. 13
- By:
- Publication type:
- Article
39
CASE STUDY: 62-year-old Caucasian woman with insulin-dependent diabetes mellitus.
- Published in:
- Ocular Surgery News, 2018, p. 5
- By:
- Publication type:
- Article
40
Travoprost delivery systems sustain IOP reduction.
- Published in:
- Ocular Surgery News, 2018, v. 36, n. 7, p. 17
- By:
- Publication type:
- Article
41
Glaukos seeks to 'transform glaucoma therapy'.
- Published in:
- Ocular Surgery News, 2018, v. 36, n. 4, p. 20
- By:
- Publication type:
- Article
42
Two iStent injects and topical travoprost reduce IOP, medication use through 18 months.
- Published in:
- Ocular Surgery News, 2017, v. 35, n. 14, p. 16
- By:
- Publication type:
- Article
43
TOP STORIES.
- Published in:
- Ocular Surgery News, 2016, v. 34, n. 21, p. 17
- Publication type:
- Article
44
Ocular Therapeutix advances sustained-release products through pipeline.
- Published in:
- Ocular Surgery News, 2015, v. 33, n. 24, p. 32
- By:
- Publication type:
- Article
45
Late-day intraocular pressure-lowering efficacy and tolerability of travoprost 0.004% versus bimatoprost 0.01% in patients with open-angle glaucoma or ocular hypertension: a randomized trial.
- Published in:
- BMC Ophthalmology, 2014, v. 14, n. 1, p. 1, doi. 10.1186/1471-2415-14-151
- By:
- Publication type:
- Article
46
Bilateral spontaneous aqueous misdirection: it can happen!
- Published in:
- Clinical & Experimental Ophthalmology, 2015, v. 43, n. 8, p. 771, doi. 10.1111/ceo.12555
- By:
- Publication type:
- Article
47
PRIMARY OPEN ANGLE GLAUCOMA; COMPARISON OF THE OCULAR HYPOTENSIVE EFFICACY OF 0.004% TRAVOPROST & 0.2% BRIMONIDINE.
- Published in:
- Professional Medical Journal, 2014, v. 21, n. 4, p. 788
- By:
- Publication type:
- Article
48
Corneal Alterations Induced by Topical Application of Commercial Latanoprost, Travoprost and Bimatoprost in Rabbit.
- Published in:
- PLoS ONE, 2014, v. 9, n. 3, p. 1, doi. 10.1371/journal.pone.0089205
- By:
- Publication type:
- Article
49
Evaluation of Topical Monotherapy for Early Primary Open Angle Glaucoma Patient.
- Published in:
- Egyptian Journal of Hospital Medicine, 2018, v. 70, n. 3, p. 403, doi. 10.12816/0043477
- By:
- Publication type:
- Article
50
Pharmacokinetics and Safety of Travoprost 0.004% Ophthalmic Solution Preserved with Polyquad in Pediatric Patients with Glaucoma.
- Published in:
- 2017
- By:
- Publication type:
- journal article